Welcome to our dedicated page for Dillards Cap I SEC filings (Ticker: DDT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Dillards Cap I's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Dillards Cap I's regulatory disclosures and financial reporting.
Dillard’s (DDS): Notice of proposed insider sale. A holder filed a Form 144 to sell up to 750 shares of Dillard’s common stock. The filing lists an aggregate market value of $442,024.80 and an approximate sale date of October 16, 2025. The shares are slated to be sold on the NYSE through Raymond James & Associates.
The shares to be sold were acquired via stock awards from the issuer on three dates: 400 shares on May 20, 2024, 100 shares on May 19, 2023, and 250 shares on May 22, 2017, with cash noted as the form of payment at acquisition.
The signer represents they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.
Chris B. Johnson, Senior Vice President of DILLARD'S, INC. (ticker shown as DDS), reported a change in beneficial ownership on 09/19/2025. The Form 4 shows a Code G transaction disposing of 100 shares of Common Class A with a reported price of $0. After the transaction, Mr. Johnson is shown as beneficially owning 9,751 shares total, including 9,270 shares associated with a retirement plan. The form is signed 09/23/2025.
Dean L. Worley, VP/General Counsel & Secretary of Dillard's, Inc. (ticker DDS), reported a transaction dated 09/17/2025 on Form 4. The filing discloses a disposition of 200 Common Class A shares (Transaction Code G) at a reported price of $0. After the transaction, Mr. Worley directly beneficially owned 6,392 Common Class A shares and held 3,483 shares in a retirement plan. The form is signed 09/18/2025.
Dillard's, Inc. (DDS) reporting person Phillip R. Watts, a Senior Vice President and director, disclosed an insider sale. The Form 4 shows a transaction dated 09/17/2025 in which Mr. Watts disposed of 500 shares of Common Class A at a reported price of $0. Following the reported transaction, he is shown as directly owning 8,894 shares and holding 10,317 shares in a retirement plan. The form is signed 09/19/2025.